Work

Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects

Year: 2020

Type: article

Source: Nature Chemical Biology

DOI: 10.1038/s41589-020-0604-z

Authors: Snehal N. Chaudhari, David A. Harris, Hassan Aliakbarian, James N. Luo, Matthew T. Henke, Renuka Subramaniam, Ashley H. Vernon, Ali Tavakkoli, Eric G. Sheu, A. Sloan Devlin

Institutions: Harvard University, Brigham and Women's Hospital

Language: English

Topic: Drug Transport and Resistance Mechanisms

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Heart Association, Harvard University, Harvard Catalyst, Boston Area Diabetes Endocrinology Research Center, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1519050663, G1621330685, G171471675, G2118519186, G3549828030, G5697257965, G643119639, Harvard Clinical and Translational Science Center, G9000011862, G9000105463, Diabetes Research Center, Human microbiome metabolites in health and disease

OpenAlex ID: W3047478453

FWCI: 6.577

Cites: 48

Cited by: 146

Related to: 10